ReWalk Robotics (Nasdaq:RWLK) announced today that it successfully demonstrated proof-of-concept with its next-generation exoskeleton. The Israel-based company, which operates out of Marlborough, Massachusetts, in the U.S., incorporated AI into its latest technology. It integrated advanced sensing technologies and AI to enable autonomous decision-making in the new exoskeleton prototype. ReWalk hit this milestone as part of […]
Prosthetics
Myomo closes $4.4M public offering
Myomo (NYSE:MYO) announced today that it closed its previously announced offering worth proceeds of approximately $4.4 million. The Boston-based wearable medical robotics maker priced its “reasonable best efforts” public offering last week. It included more than 7.3 million shares of common stock priced at 60¢ per share. Members of management, affiliated investors and certain high-quality, […]
Myomo prices $4.4M offering, scores reimbursement win
Myomo (NYSE:MYO) announced today that it priced a “reasonable best efforts” public offering worth proceeds of approximately $4.4 million. Boston-based Myomo’s offering includes more than 7.3 million shares of common stock priced at 60¢ per share. The company expects to close the offering on or about Aug. 29, 2023, subject to customary conditions. Myomo develops […]
ReWalk stock dips on Q2 EPS miss
ReWalk Robotics (Nasdaq:RWLK) shares fell today on second-quarter results that came in mixed compared to the consensus forecast. Shares of RWLK dipped 1.8% at 71¢ apiece in mid-afternoon trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — remained even. The Yokneam Illit, Israel-based company posted losses […]
ReWalk Robotics to acquire anti-gravity tech provider AlterG for $19M
ReWalk Robotics (Nasdaq:RWLK) announced that it executed an agreement to acquire AlterG, an anti-gravity system provider. The deal includes a purchase price of approximately $19 million at closing. ReWalk expects to close the deal on Aug. 11, with closing contingent upon the satisfaction of customary closing conditions. Additional cash earnouts may be paid based upon […]
Myomo prices $6.5M public offering
Myomo (NYSE:MYO) announced today that it priced a public offering of 20 million shares of common stock at $0.325 per share. Boston-based Myomo expects aggregate gross proceeds to total approximately $6.5 million. That comes before deducting placement agent fees and other offering expenses. The company expects the offering to close on or about Jan. 17, […]
Össur acquires finger prosthetics company Naked Prosthetics
Össur (NSDQ:OSSR) announced today that it acquired Naked Prosthetics and its offerings for finger and partial hand amputees. Hämeenlinna, Finland-based Össur’s acquisition of Naked Prosthetics, a developer of mechanical devices individually designed to mimic the natural motion of the finger, went into effect on Aug. 26, 2022. The company said in a news release that […]
FDA clears Ekso Bionics’ robotic exoskeleton for use with MS patients
Ekso Bionics (Nasdaq:EKSO) announced today that it received FDA 510(k) clearance for its EksoNR robotic exoskeleton. Richmond, California–based Ekso Bionics designed the EksoNR technology for use with Multiple Sclerosis (MS) patients. According to a news release, EksoNR is the first exoskeleton device to receive FDA clearance for rehabilitation use in patients with MS, significantly expanding […]
Myomo slides as Q4 earnings miss despite massive sales beat
Myomo (NYSE:MYO) shares were down this morning on fourth-quarter results that were mixed compared to the consensus forecast. The Boston-based medical robotics company posted losses of $2.7 million, or 52¢ per share, on sales of $4 million for the three months ended Dec. 31, 2021, for a bottom-line slide deeper into the red on sales […]
What happens when bionic eye implants suddenly go dark?
An update on the Second Sight Medical Products (NASDAQ:EYES) saga comes to us by way of IEEE Spectrum, offering a cautionary tale for the developers of cutting-edge implants and the patients who place their faith in them. The future remains cloudy for the Los Angeles–based developer of the Argus 2s retinal prosthesis system, which is […]
Myomo touts independent study of its MyoPro myoelectric orthosis
Myomo (NYSE:MYO) announced today that new research demonstrated benefits with its MyoPro myolectric orthosis for the upper limbs. Results from the study, funded by the U.S. Army Medical Research Acquisition Activity, and supported by the Office of Secretary of Defense for Health Affairs, were published in the peer-reviewed journal Frontiers in Neurology. Data showed “statistically significant improvements” […]
